JPMORGAN CHASE & CO - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 49 filers reported holding LUMOS PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$116
+75.8%
35
+75.0%
0.00%
Q2 2023$66200.0%0.00%
Q1 2023$0200.0%0.00%
Q4 2022$020
-31.0%
0.00%
Q3 2022$029
+190.0%
0.00%
Q4 2020$0100.00%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 10,175$70,512,0000.26%
Minerva Advisors LLC 34,015$236,0000.14%
Investors Financial Group, LLC 30,600$212,0000.10%
Lion Point Capital, LP 51,205$354,0000.10%
NEA Management Company, LLC 376,916$2,612,0000.05%
Wealth Advisors of Iowa, LLC 11,699$81,0000.04%
Paladin Advisory Group, LLC 4,382$30,0000.02%
Marquette Asset Management, LLC 13,315$92,0000.02%
Blackstone Inc. 468,145$3,244,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$331,0000.01%
View complete list of LUMOS PHARMA INC shareholders